Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma
NCT01073410 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2022-02-01
Summary
The purpose of this study is to find out the roles of two specific gene families (the chitinase gene family and the TGFB family). We hypothesize that chitinases and TGFb pathway genes will be differentially expressed in the airways of non-asthmatic subjects and subjects with asthma. We further hypothesize that genetic variants in CHIT1, AMCase, and TGFb pathway genes that show associations with asthma and related phenotypes will change the expression and/or function of the protein of these genes in the airway in several ways, including the transcript numbers for full length genes and splice variants and, for the chitinase genes, the levels of chitinase activity in airway secretions.
Conditions
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
University of California, San Francisco
lead OTHER
Principal Investigators
-
John G Fahy, MD · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2017-02-28
- Completion
- 2021-04-30
Countries
- United States
Study Locations
More Related Trials
-
Mechanisms of Exacerbation of Asthma
NCT00594750 ·Status: TERMINATED
-
Association Between Genetic Polymorphisms and Type 2 Asthma in Children
NCT06840717 ·Status: RECRUITING
-
Genetic Risk Factors for Severe Asthma
NCT00090740 ·Status: COMPLETED
-
Role of T-Cells in Asthma
NCT00001408 ·Status: COMPLETED
-
Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects
NCT01554319 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins
NCT04514926 ·Status: COMPLETED
-
Identification of an Asthma Susceptibility Gene on 3P
NCT00006510 ·Status: COMPLETED
-
ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression
NCT06869382 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Eosinophils in the Proliferation of Airway Smooth Muscle (ASM) Cells
NCT01082952 ·Status: COMPLETED
-
Factors Involved in Asthma and Airway Inflammation
NCT00001887 ·Status: COMPLETED
-
Genetic Studies in Difficult to Treat Asthma: TENOR
NCT00091767 ·Status: COMPLETED
-
Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma
NCT00187499 ·Status: COMPLETED ·Phase: NA
-
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
NCT00367016 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma
NCT04706988 ·Status: RECRUITING
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Identification of Asthma Phenotypes in Severe Asthmatics
NCT01623089 ·Status: RECRUITING
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Histoblood Group Antigens as a Risk Factor of Asthma
NCT00201266 ·Status: COMPLETED
-
Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
NCT02659618 ·Status: COMPLETED
-
Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects
NCT01470911 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Biomarkers in the Occurrence and Development of Asthma
NCT05768399 ·Status: RECRUITING
-
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment
NCT01537133 ·Status: COMPLETED ·Phase: NA
-
This is a 6-month Observational Study. Patients Included Will be Those Referred With a Possible Diagnosis or an Established Diagnosis of Asthma. It Will Look at the Association of the Asthma Microbiome and Disease Characteristics, Severity and Treatment Response.
NCT06028204 ·Status: UNKNOWN